Innovative Medicines Canada (IMC) helps their members discover, develop, and deliver innovative medicines and vaccines.
Their membership consists of more than 50 companies, from established organizations to fledgling startups, all of whom are revolutionizing healthcare through the discovery and development of new medicines and vaccines.
Guided by a strict Code of Ethical Practices, IMC work with governments, insurance companies, healthcare professionals and stakeholders to advance the field and enhance the wellbeing of Canadians. They are committed to being valued partners in Canada’s healthcare system.
IMC aims to achieve these goals by forming effective alliances, supporting policies, improving Canada’s regulatory environment, widening access to innovative medicines and ensuring the effective protection of intellectual property.
BioTalent Canada supports the people behind life-changing science. Trusted as the go-to source for labour market intelligence, BioTalent Canada guides bio-economy stakeholders with evidence-based data and industry-driven standards. BioTalent Canada is focused on igniting the industry’s brainpower, bridging the gap between job-ready talent and employers, and ensuring the long-term agility, resiliency, and sustainability of one of Canada’s most vital sectors.
MNP is a leading national accounting, tax and business consulting firm in Canada. They proudly serve and respond to the needs of their clients in the private, public and not-for-profit sectors. Through partner-led engagements, MNP provides a collaborative, cost-effective approach to doing business and personalized strategies to help people and organizations succeed across the country and around the world.
AstraZeneca is a science-led biopharmaceutical company pushing the boundaries of science to deliver life-changing medicines.
The company employs more than 700 people in Canada who work to research, develop and market innovative medicines. AstraZeneca Canada was recently designated a global Clinical Hub for oncology and immuno-oncology clinical studies. We are currently leading global oncology clinical studies in lung, head and neck cancer.
Innovacorp is Nova Scotia’s early stage venture capital organization. The organization finds, funds, and fosters innovative Nova Scotia start-ups that strive to change the world.
Innovacorp is especially interested in start-ups in the information technology, life sciences, clean technology and ocean technology sectors. They want to help those companies commercialize their technologies and succeed in the global marketplace.
MERCK is a global healthcare company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products.
For more than 130 years, Merck has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. Merck demonstrates a commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships.
Grant Thornton is an independent, knowledgeable and experienced audit, tax, and accounting firm. They are committed to being proactive in bringing their clients timely information and advice, and their partners are accessible to their clients.
Grant Thornton provides a team-based approach and dedication to partner or senior professional involvement and regular client contact — for every client, for every engagement.
Novo Nordisk Canada Inc. is an affiliate of Novo Nordisk A/S, a global healthcare company with more than 90 years of innovation and leadership in diabetes care.
This heritage has given them experience and capabilities that enable them to help people defeat other serious chronic conditions such as hemophilia, growth disorders and obesity.
Boehringer Ingelheim was Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Approximately 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health and Biopharmaceutical Contract Manufacturing.
The Canadian headquarters of Boehringer Ingelheim was established in 1972 in Montreal, Quebec and is now located in Burlington, Ontario. Boehringer Ingelheim employs approximately 600 people across Canada.